MARC HOROWITZ to Rhabdomyosarcoma
This is a "connection" page, showing publications MARC HOROWITZ has written about Rhabdomyosarcoma.
Connection Strength
0.257
-
Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol. 1993 Oct; 11(10):1911-8.
Score: 0.088
-
Hepatic undifferentiated (embryonal) sarcoma and rhabdomyosarcoma in children. Results of therapy. Cancer. 1987 Feb 01; 59(3):396-402.
Score: 0.056
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.026
-
Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer. 1992 Nov; 5(4):299-310.
Score: 0.021
-
Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2.
Score: 0.017
-
The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma. Arch Surg. 1987 Dec; 122(12):1451-4.
Score: 0.015
-
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution. J Clin Oncol. 1986 Apr; 4(4):559-64.
Score: 0.013
-
Combination of dacarbazine and doxorubicin in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rep. 1985 Sep; 69(9):999-1000.
Score: 0.013
-
Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg. 1995 Jun; 59(6):1385-9; discussion 1390.
Score: 0.006
-
Chromosome 1 abnormalities: a common feature of pediatric solid tumors. J Natl Cancer Inst. 1985 Jul; 75(1):51-4.
Score: 0.003